BACK TO LATEST EDITIONS
DECEMBER 21, 2023
Happy Holidays from CRN / Register now for complimentary FSA & HSA webinar / Nature's Bounty beats class action / And more
DECEMBER 14, 2023
Mister reports from Q4 board of directors meeting / Addressing exporter certification issues in Turkey / And more
DECEMBER 7, 2023
Membership renewal forms due tomorrow / CRN's membership team expands / And more
NOVEMBER 30, 2023
CRN meets with FDA’s Jim Jones / CRN-I conference report published / And more
NOVEMBER 16, 2023
CRN on the ground in Massachusetts / ‘CRN Supplement’ on hiatus for Thanksgiving / And more
NOVEMBER 14, 2023
INTERIM ALERT: JAMA Letter on increasing pediatric melatonin use merely underscores popularity of safe products
NOVEMBER 9, 2023
NOVEMBER 3, 2023
INTERIM ALERT: No clarification from FDA on drug preclusion issue disappointing, CRN says
NOVEMBER 2, 2023
Clock ticking on FDA response to drug preclusion Citizen Petition / NY age restrictions present ‘watershed moment’ / Mexico blocks supplement shipments / And more
OCTOBER 26, 2023
Age restriction legislation passed in NY / Don't miss complimentary webinar on supplements and the U.S. Military / And more
OCTOBER 25, 2023
INTERIM ALERT: New York age restriction legislation signed into law
OCTOBER 19, 2023
Mister calls for focused, centralized industry voice / EPR legislation round up / And more
OCTOBER 12, 2023
Mister, Martin reflect on CRN's impact in 'Now Now Next' addresses / Attention marketers—committee expanding / See you at SupplySide West / And more
OCTOBER 5, 2023
FDA Commissioner Califf questions claims / Supplement users agree they are essential to maintaining health / Meet the 2023 CAPS winners / And more
SEPTEMBER 28, 2023
Access valuable data on today’s supplement consumer / Don’t miss CRN hydration innovation panel at SupplySide West / And more
SEPTEMBER 27, 2023
INTERIM ALERT: Systematic review/meta-analysis finds no link between calcium supplementation and risk of negative cardiovascular outcomes
SEPTEMBER 21, 2023
Reflecting on our founding values and DSHEA modernization / Petition to FTC on substantiation guidance / And more
SEPTEMBER 14, 2023
Supplementation in the Dietary Guidelines / Understanding today’s supplement consumer / Connect with CRN at Expo East
SEPTEMBER 7, 2023
Last chance to book at best rates for CRN events—don't miss CEO session with Pharmavite's Jeff Boutelle and other industry leaders / And more
AUGUST 31, 2023
Book now—conference room block closes tomorrow / Senators seek details on FDA reorg proposal / Preorder new CRN Consumer Survey for best value / And more
AUGUST 24, 2023
Catch up on a busy August in Washington / FDA Commissioner to speak during 'Now New Next' / Building brands that resonate with consumers / And more
AUGUST 22–23, 2023
INTERIM ALERT: JAMA Cardiology article on ‘Health Claims and Doses of Fish Oil Supplements in the U.S.’
AUGUST 18, 2023
INTERIM ALERT: FDA Is Failing Consumers on CBD
AUGUST 17, 2023
FDA master file guidance lacks enforcement protocols / Get to know a visionary CEO / Media mentions / And more
AUGUST 10, 2023
CRN recommends delayed implementation for Health Canada’s cost recovery proposal / Join the fun at our annual conference / And more
AUGUST 3, 2023
JULY 27, 2023
CBD in the spotlight / The giant weakness in the supply chain right now / Register for 50th anniversary events by Aug. 4
JULY 20, 2023
FSA/HSA legislation introduced / Profiles in leadership / 'Nothing new' revealed by JAMA letter on botanical sports supplements
JULY 13, 2023
Letter to FDA Commissioner notes concerns about proposed reorganization / Mason Vitamins' Tacl appointed Retailer Relations Forum Chair / Media mentions / And more
JULY 6, 2023
INTERIM ALERT: CRN CEO Member Update on Proposed FDA Foods Program Reorg.
FTC revised endorsement guide released / Aspartame safety in question / and more
JUNE 29, 2022
TiO2 update in California / Science in Session agenda, speaker lineup / CRN in the news / and more
JUNE 22, 2023
‘Day on the Hill’ brings members face-to-face with legislators, staff / Member CROs comment on updated clinical trial guidance / And more
JUNE 15, 2023
Supplements for better brain health / Consumer Survey Advisory Committee reconvenes / CRN at IADSA World Supplement Forum / And more
JUNE 8, 2023
‘Science in Session’ publication explores gaps, opportunities in optimizing health with nutrition / CRN continues pushback on NY age restrictions at executive branch level / And more
JUNE 1, 2023
More science behind the supplements / Melatonin in focus / June calendar / And more
MAY 25, 2023
Good news about multivitamins / FDA CBD stakeholder session today / Legal claims for non-lawyers / Catch up on producer packaging responsibility / And more
MAY 23, 2023
INTERIM ALERT: FDA CBD stakeholder call Thursday, May 25, at 3 pm Eastern
MAY 18, 2023
Mister emphasizes melatonin safety / Catch up on counterfeiting / Doing better by women in the workplace as well as in nutrition policy
MAY 11, 2023
FDA Drug Preclusion Clause interpretation threatens innovation, consumer choice / Day on the Hill back in person June 21 / Melatonin Task Force reconvenes / And more
MAY 10, 2023
INTERIM ALERT: Citizen Petition calls on FDA to reconsider Drug Preclusion Clause interpretation
MAY 4, 2023
Mister talks 2023 policy priorities—drug preclusion and more / Complimentary educational opportunities for CRN members / Be part of CRN history
APRIL 27, 2023
JAMA Research Letter on melatonin gummies / CRN monitoring state packaging, age restriction legislation / BSCG reports from Partnership for Clean Competition Conference — and more
APRIL 25, 2023
INTERIM ALERT: JAMA Research Letter raises false alarm over levels of melatonin in gummies
APRIL 24, 2023
INTERIM ALERT: Embargoed—Melatonin gummies topic of JAMA Research Letter
APRIL 20, 2023
FTC penalty offense notices / Supporting Codex sustainability efforts / FSA and HSA holders want supplements covered / And more
APRIL 13, 2023
Supplements and pregnancy / WellComms to offer streaming virtual option / Case by case enforcement discretion won’t solve drug preclusion issues – And more
APRIL 6, 2023
Reaching influential RDs with science-based info on supplements / CRN committee meetings & Toxicology Workshop next week / And more
MARCH 30, 2023
FDA must prioritize supplements / CRN and members in the news / And more
MARCH 23, 2023
Engaging on sustainability solutions / Protecting supplement access in the states / And more
MARCH 16, 2023
What’s next for CBD? / State age-restriction proposals persist—CRN in Maryland today / And more
MARCH 9, 2023
Elevating supplements as essential to public health / Report from ExpoWest, Codex, and more
